InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Scholar Rock Holding Corp

SRRK Clue Score52
United States Fiscal year ends December CIK 0001727196 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Balanced

Individual transactions

63
Insider
Date
Role
Action
Shares
Price
Amount
David Hallal
16 Apr 2026
Chief Executive Officer
Sell
30,615
$49.57
$1.52M
Vikas Sinha
16 Apr 2026
Chief Financial Officer
Sell
10,410
$49.57
$516.07K
Akshay Vaishnaw
16 Apr 2026
President of R&D
Sell
12,246
$49.57
$607.09K
Keith Woods
16 Apr 2026
Chief Operating Officer
Sell
10,220
$49.57
$506.65K
Mo Qatanani
17 Feb 2026
Chief Scientific Officer
Sell
7,989
$46.53
$371.71K
Caryn Parlavecchio
17 Feb 2026
CHRO
Sell
9,035
$46.53
$420.38K
Junlin Ho
17 Feb 2026
General Counsel
Sell
9,580
$46.53
$445.74K
Jing L. Marantz
17 Feb 2026
Chief Medical Officer
Sell
4,157
$46.53
$193.42K
Junlin Ho
16 Jan 2026
General Counsel
Sell
8,016
$44.48
$356.53K
Jing L. Marantz
16 Jan 2026
Chief Medical Officer
Sell
5,798
$44.48
$257.88K
Caryn Parlavecchio
16 Jan 2026
CHRO
Sell
6,600
$44.48
$293.55K
Mo Qatanani
16 Jan 2026
Chief Scientific Officer
Sell
8,406
$44.48
$373.88K
David Hallal
13 Jan 2026
Chief Executive Officer
Sell
57,450
$42.70
$2.45M
Akshay Vaishnaw
13 Jan 2026
President of R&D
Sell
20,438
$42.70
$872.70K
Keith Woods
13 Jan 2026
Chief Operating Officer
Sell
16,746
$42.70
$715.05K
Vikas Sinha
13 Jan 2026
Chief Financial Officer
Sell
16,755
$42.70
$715.44K
Mo Qatanani
22 Sep 2025
Chief Scientific Officer
Sell
3,353
$30.67
$102.85K
Mo Qatanani
16 Sep 2025
Chief Scientific Officer
Sell
3,178
$33.52
$106.53K
Caryn Parlavecchio
18 Aug 2025
CHRO
Sell
2,178
$31.17
$67.88K
Junlin Ho
16 Jun 2025
General Counsel
Sell
7,442
$32.00
$238.15K
Caryn Parlavecchio
16 Jun 2025
CHRO
Sell
6,186
$32.00
$197.96K
Mo Qatanani
16 Jun 2025
Chief Scientific Officer
Sell
3,668
$32.00
$117.38K
Jay T. Backstrom
18 Feb 2025
Chief Executive Officer
Sell
18,372
$36.83
$676.62K
Junlin Ho
18 Feb 2025
General Counsel
Sell
5,742
$36.83
$211.47K
Edward H Myles
18 Feb 2025
COO & CFO
Sell
7,809
$36.83
$287.60K
Caryn Parlavecchio
18 Feb 2025
CHRO
Sell
5,296
$36.83
$195.05K
Junlin Ho
16 Jan 2025
General Counsel
Sell
9,039
$44.20
$399.50K
Edward H Myles
16 Jan 2025
COO & CFO
Sell
12,539
$44.20
$554.19K
Caryn Parlavecchio
16 Jan 2025
CHRO
Sell
6,434
$44.20
$284.36K
Mo Qatanani
16 Jan 2025
Chief Scientific Officer
Sell
7,347
$44.20
$324.72K
Tracey Sacco
16 Jan 2025
Chief Commercial Officer
Sell
3,890
$44.20
$171.93K
Jing L. Marantz
16 Jan 2025
Chief Medical Officer
Sell
5,655
$44.20
$249.94K
Jay T. Backstrom
16 Jan 2025
Chief Executive Officer
Sell
22,308
$44.20
$985.95K
Invus Public Equities, L.P.
10 Dec 2024
10% owner
Sell
1,600,000
$41.65
$66.64M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
149
$40.98
$6.11K
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
30,683
$40.14
$1.23M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
126,442
$39.51
$5.00M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
43,887
$38.43
$1.69M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
208,272
$37.63
$7.84M
Mo Qatanani
16 Sep 2024
Chief Scientific Officer
Sell
1,936
$8.58
$16.61K
Caryn Parlavecchio
16 Aug 2024
CHRO
Sell
1,451
$9.33
$13.54K
Junlin Ho
17 Jun 2024
General Counsel
Sell
4,695
$8.98
$42.18K
Edward H Myles
17 Jun 2024
COO & CFO
Sell
9,458
$8.98
$84.98K
Caryn Parlavecchio
17 Jun 2024
CHRO
Sell
4,305
$8.98
$38.68K
Mo Qatanani
17 Jun 2024
Chief Scientific Officer
Sell
2,315
$8.99
$20.80K
Jay T. Backstrom
16 Feb 2024
Chief Executive Officer
Sell
11,614
$15.74
$182.84K
Junlin Ho
16 Feb 2024
General Counsel
Sell
3,489
$15.74
$54.93K
Caryn Parlavecchio
16 Feb 2024
CHRO
Sell
3,751
$15.74
$59.05K
Mo Qatanani
16 Feb 2024
Chief Scientific Officer
Sell
2,512
$15.74
$39.55K
Edward H Myles
16 Feb 2024
COO & CFO
Sell
4,744
$15.74
$74.69K
Junlin Ho
16 Jan 2024
General Counsel
Sell
4,186
$15.93
$66.68K
Edward H Myles
16 Jan 2024
COO & CFO
Sell
6,634
$15.93
$105.67K
Caryn Parlavecchio
16 Jan 2024
CHRO
Sell
2,849
$15.93
$45.38K
Mo Qatanani
16 Jan 2024
SVP and Head of Research
Sell
2,002
$15.93
$31.89K
Mo Qatanani
18 Sep 2023
SVP and Head of Research
Sell
1,945
$6.34
$12.33K
Caryn Parlavecchio
16 Aug 2023
CHRO
Sell
1,353
$6.83
$9.24K
Invus Public Equities, L.P.
9 Jan 2023
10% owner
Sell
1,094
$9.48
$10.37K
Jeffrey S. Flier
1 Oct 2021
Director
Sell indirect
6,000
$30.89
$185.33K
Jeffrey S. Flier
20 Sep 2021
Director
Sell
500
$34.09
$17.05K
Jeffrey S. Flier
26 Jul 2021
Director
Sell indirect
3,037
$31.48
$95.61K
Jeffrey S. Flier
26 Jul 2021
Director
Sell indirect
2,963
$31.84
$94.35K
Michael Gilman
15 Mar 2021
Director
Sell
4,696
$65.59
$308.00K
Michael Gilman
8 Feb 2021
Director
Sell
1,804
$65.06
$117.36K
Show all 194 transactions →

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 44
Sales straight out of an exercise 49
Sales at will 63
Transactions with no price 0
Shares from compensation/vesting 30,452,736
Sales filed before the plan box existed 7
History held since 31 May 2018